返回 Agenda
DS.S1. – Responsible Innovation: Governance, Transparency and Future of AI
Session Chair(s)
Anitha Kumari
Head of Clinical Data Management, Sanofi, India
This session will examine the evolving regulatory landscape and how pharmaceutical companies are adopting AI responsibly. A keynote presentation will set the stage, followed by a panel discussion addressing key issues: balancing innovation with GxP compliance, ensuring data privacy and transparency, AI governance in wearables, and the rise of DCTs and smart platforms. Experts will share insights on building trustworthy, compliant, and patient-centric AI systems. The session aims to provide practical perspectives on navigating the fine line between innovation and responsibility in a rapidly advancing digital health ecosystem.
Speaker(s)
Ashwini Kumar Mathur, PHD
Executive Director, Onesto Consulting, Ireland
Evolution of Regulatory Landscape and Adoption by Pharma Companies
Kishore Kumar
Co-Founder and Chief Data Scientist, ConsilX Digital, India
With the Additional participation of:
Priya Kulkarni
, Consultant/Advisor- Healthcare(Pharma|Diagnostics | Digital Health), India
With the Additional participation of:
Anuprita Sheth
Vendor Capacity & Management, APAC & Global Lead, KENVUE, India
With the Additional participation of: